Introduction
Introduction
A hallmark feature of aggressive cancers is a general increase in protein synthesis and protein degradation, both of which are required to increase tumour growth [1] . There are two major protein degradation systems in cells, the proteasome pathway and the autophagy pathway. The roles of these pathways in regulating cell growth, survival and metastasis of cancer cells make them attractive therapeutic targets [2] [3] [4] . Consistent with this idea, the proteasome inhibitor bortezomib (BZ; Velcade), is currently being used for the treatment of multiple myeloma and mantle cell lymphoma. Autophagy is a bulk degradation pathway that degrades unwanted proteins and defective organelles [5] . However, cancer cells can activate this pathway to recycle proteins to generate energy in an attempt to survive stressful conditions [6, 7] . [8] . [9] . The induction of autophagy has been observed in malignant cells following treatment with a number of cancer therapeutics including arsenic trioxide, rapamycin, histone deacetylase (HDAC) inhibitors, tamoxifen, imatinib and ionizing radiation [10] [11] [12] [13] [14] [15] . Although rigorous testing is required to fully elucidate the consequences of autophagy induction for the activity of individual treatments, it could significantly compromise efficacy by providing cancer cells with a mechanism to combat therapeutic stress. Therefore, inhibition of autophagy may be a promising novel strategy with broad applications in cancer therapy.
Preclinical studies conducted with an Akt-driven tumour model established that autophagy is preferentially activated in tumour cells during the early stages of tumorigenesis when the vasculature is immature and nutrients and oxygen are limited

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation
Chloroquine (CQ) is a synthetic 4-aminoquinoline that has been used for more than 60 years in human beings for the treatment of rheumatoid arthritis (RA) [16] and HIV and the prophylaxis and treatment of malaria [17, 18] . CQ functions as a weak base and is trapped in acidic cellular compartments including lysosomes [19] . Thus, deacidification of lysosomes by CQ impairs the activity of most lysosomal proteases due to their strict pH requirements. Consequently, CQ inhibits the last step in the autophagic degradation process [20] . Here 
Materials and methods
Animals and cell lines
Transmission electron microscopy
Transmission electron microscopy of cells was performed as previously described [22] . 
Results
Chloroquine and bortezomib stimulate ubiquitin-conjugated protein accumulation in colon cancer cells
CQ disrupts lysosomal function and inhibits the last step in the autophagic degradation process [20]. Consistent with this mechanism of action, CQ treatment induced lipid modification of LC3-I into LC3-II and increased the expression and cytosolic localization of cathepsin D (Fig. 1A). We suggested that CQ treatment would result in an accumulation of proteins normally degraded by autophagy. Inhibition of proteasomal activity with BZ or autophagy with CQ resulted in the accumulation of ubiquitinated proteins in colon cancer cells as assessed by immunoblotting (Fig. 1B). However, inhibition of autophagy with CQ induced a much slower rate of protein accumulation as compared with proteasomal inhibition (Fig. 1C). Analysis of the subcellular distribution of these ubiquitin conjugates by immunofluorescent anti-ubiquitin staining and confocal microscopy revealed that BZ stimulated perinuclear aggresome formation, whereas CQ induced lysosomal accumulation of these aggregates (Fig. 1D).
HDAC inhibition disrupts BZ-induced aggresome formation, but enhances CQ-mediated ubiquitinated protein accumulation
We previously demonstrated that BZ stimulates aggresome formation and that HDAC inhibition disrupts this process in pancreatic cancer and multiple myeloma models [3, 21] . Consistent with these results, we observed aggresome formation and disruption in HT29 and HCT8 colon cancer cell lines following 24 hrs of BZ and BZ/VOR treatment ( Fig. 2A and B) . A 48-hr exposure to CQ stimulated lysosomal ubiquitinated protein accumulation and this effect was strongly augmented by the addition of VOR ( Fig. 2A and B) . The protein aggregates were organized as electron dense particles when visualized by transmission electron microscopy ( Fig. 2C) . 3B ) and DNA fragmentation (Fig. 3C ). In addition, this drug combination also led to a significant reduction in clonogenic survival (Fig. 3D) . We have previously demonstrated that inhibiting protein synthesis with CHX blocks BZ and BZϩVOR-mediated apoptosis in multiple myeloma and pancreatic cancer models [3, 22] . Consistent with these results, CHX also prevented ubiquitinated protein accumulation in HCT8 colon cancer cells treated with BZ and CQ (Fig. 3E) and apoptosis induced by the CQϩVOR or CQϩ3-MA combinations (Fig. 3F) . [27, 28] . To (Fig. 5C ) and significantly reduced CQϩVOR-induced apoptosis (Fig. 5D) . (Fig. 6A) .
4C). Silencing of HDAC6 strongly enhanced BZ-mediated apoptosis (Fig. 4C) and disrupted aggresome formation (Fig. 4D). However, knockdown of HDAC6 only marginally increased apoptosis stimulated by CQ or 3-MA (Fig. 4C) and did not alter ubiquitinated protein localization following CQ exposure (Fig. 4D), suggesting that VOR enhances CQ and 3-MAinduced apoptosis via another mechanism. Several studies have reported that VOR induces oxidative stress and that this effect contributes to its anticancer activity
Effects of CQ and SAHA on HCT8 colon cancer tumours
In a final series of experiments we investigated the effects of CQ, VOR and the combination on tumour growth and cell death in the HCT8 colon cancer xenograft model. Established tumours were treated daily with 60 mg/kg CQ, 100 mg/kg VOR or both agents for 21 days. Combination therapy significantly reduced colon tumour weight as compared to therapy with either agent alone
Importantly, no signs of toxicity or weight loss were observed in mice in any treatment group (data not shown). Therapy with either CQ or VOR alone stimulated moderate increases in tumour cell apoptosis as measured by TUNEL staining, whereas combination therapy resulted in significantly higher levels of apoptosis (Fig. 6B and C). These data demonstrate that therapy of CQ in combination with VOR is well tolerated and induces tumour cell death and warrants further evaluation for the treatment of colon cancer.
Discussion
The proteasomal and lysosomal systems are the two major protein degradation pathways in eukaryotic cells. Autophagy is the main mechanism by which cytoplasmic molecules are delivered to the lysosome [29] and is required for the turnover of cellular components activated under nutrient-deficient conditions [30] . Furthermore, autophagy has been implicated in cancer as a survival mechanism in response to chemotherapy and hypoxia [23, [31] [32] [33] [34] . Inhibition of proteasomal degradation with BZ has demonstrated promising anticancer activity in numerous preclinical models and is approved for the treatment of multiple myeloma and mantle cell lymphoma [35] . Here we investigated the anticancer potential of inhibiting autophagic degradation for the treatment of colon cancer. [7, 31] . Similar to BZ, treatment with CQ also leads to an accumulation of ubiquitinconjugated proteins. However, CQ-mediated protein build-up occurs at a much slower rate than BZ, which is consistent with the idea that autophagic protein turnover degrades long-lived proteins, whereas the proteasome accounts for rapid short-lived protein degradation [36] . [36] [37] [38] . Proteasomes require unfolded proteins for degradation [39] [3, 21, 25, 40] . Because CQ treatment also induced ubiquitinated protein accumulation, we compared the effect that VOR would have on BZ-and CQ-mediated ubiquitin-conjugated protein accumulation and apoptosis. Consistent with our data in other cancer types [3, 21] , BZ stimulated aggresome formation in colon cancer cells, which was disrupted by the addition of VOR or targeted knockdown of HDAC6. Surprisingly, the addition of VOR led to a more pronounced To elucidate the mechanism(s) of CQ/VOR-mediated apoptosis, we knocked down the expression levels of Atg7, an essential gene required for autophagy [36] [27, 28, 41, 42] [31] . Because this alkylating agent is also known to induce oxidative stress [44] 
The lysosomotropic agent CQ disrupts lysosomal function and inhibits autophagy by interfering with the acid-dependent degradation of proteins within the autophagosome
CQ treatment did not inhibit proteasomal activity (data not shown). In accordance with this result, CQmediated ubiquitin-conjugated protein accumulation differs from BZ in that these proteins remain within the lysosomal compartment and do not form aggresomes. Our data is in agreement with observations made in Atg7-or Atg5-deficient cells, which also formed ubiquitin-positive aggregates
